Find a Specialist by Name | Page 3 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Find a Specialist by Name

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Name Institution City State Country Disease Expertise
Karyn Brundige, MSN, CPNP Dana-Farber Cancer Institute Boston Massachusetts United States
  • Pediatric
Andrew Brunner Harvard Medical School Boston Massachusetts United States
  • Myelodysplastic Syndromes (MDS)
Rena Buckstein, MD, FRCP Odette Cancer Center - Sunnybrook Health Sciences Centre Toronto Ontario Canada
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
Michael Burke, MD Children's Wisconsin-Milwaukee Hospital Milwaukee Wisconsin United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Pediatric
Michael Byrne, DO Vanderbilt Medical Center Nashville Tennessee United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Rodrigo Calado, MD, PhD Hospital das Clínicas de Ribeirão Preto Ribeirão Preto São Paulo Brazil
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Katherine Calvo, MD, PhD National Institutes of Health Bethesda Maryland United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
Hetty Carraway, M.D. The Cleveland Clinic Taussig Cancer Institute Cleveland Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Namrata Chandhok, MD University of Miami Health System - Sylvester Comprehensive Cancer Center Miami Florida United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Guang-Shing Cheng, M.D. Fred Hutchinson Cancer Research Center Seattle Washington United States
  • Graft Versus Host Disease (GVHD)
Saurabh Chhabra, MD, MS Froedtert Hospital and the Medical College of Wisconsin Milwaukee Wisconsin United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Satheesh Chonat, MD Children’s Healthcare of Atlanta Atlanta Georgia United States
  • Aplastic Anemia
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
Stephen Chung, MD UT Southwestern Medical Center Dallas Texas United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Christopher Cogle, MD University of Florida Health Cancer Center Gainesville Florida United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Jonathon B. Cohen, MD, MS Emory University Atlanta Georgia United States
Robert Collins, MD Harold C. Simmons Comprehensive Cancer Center Dallas Texas United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Kenneth R. Cooke, MD Johns Hopkins University Baltimore Maryland United States
  • Graft Versus Host Disease (GVHD)
  • Pediatric
Mehmet Copur, MD, FACP Marylanning Health Care Hastings Nebraska United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Seth Corey, MD, MPH Cleveland Clinic – Lerner Research Institute Cleveland Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
Jorge Cortes, MD Augusta University Augusta Georgia United States
  • Acute Myeloid Leukemia (AML)
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)